Detailed evaluation of dyskinesias using multiple endpoints in a randomized, placebo-controlled trial of Parkinson's disease patients with motor fluctuations

被引：0
|
作者：
Kenney, C.
Kieburtz, K.
Olanow, W.
Bandak, S.
机构：
来源：
MOVEMENT DISORDERS | 2016年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
2097
引用
收藏
页码：S693 / S693
页数：1
相关论文
共 50 条
  • [31] Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial
    Ghodsi, Hamidreza
    Rahimi, Hamid Reza
    Aghili, Seyedeh Mehrnaz
    Saberi, Amin
    Shoeibi, Ali
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 218
  • [32] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
    DiFrancisco-Donoghue, Joanne
    Rabin, Ely
    Lamberg, Eric M.
    Werner, William G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
  • [33] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
    Chong, K. K.
    Lim, S. Y.
    Manap, M. A. A. A.
    Lim, J. L.
    Low, S. C.
    Mahadeva, S. K.
    Tan, A. H.
    MOVEMENT DISORDERS, 2018, 33 : S194 - S194
  • [34] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
    Wong, Kitty K.
    Alty, Jane E.
    Goy, Amanda G.
    Raghav, Sanjay
    Reutens, David C.
    Kempster, Peter A.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
  • [35] A randomized, double-blind, placebo-controlled trial of hydrogen water in Parkinson's disease
    Yoritaka, A.
    Takanashi, M.
    Hirayama, M.
    Ohta, S.
    Hattori, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 311 - 311
  • [36] A Pilot Randomized Placebo-Controlled Trial of Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
    Altman, Robert
    Lang, Anthony
    Munhoz, Renato
    Charand, Katia
    Wadup, Lisa
    Postuma, Ronald
    NEUROLOGY, 2011, 76 (09) : A275 - A275
  • [37] Impact of tDCS in Parkinson's disease on mood, cognition, and motor deficits: A randomized, double-blinded, placebo-controlled trial
    Falconer, R. A.
    Rogers, S. L.
    Torres-Yaghi, Y.
    Turkeltaub, P.
    Pagan, F.
    MOVEMENT DISORDERS, 2015, 30 : S81 - S81
  • [38] A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
    Richard, I. H.
    McDermott, M. P.
    Kurlan, R.
    Lyness, J. M.
    Como, P. G.
    Pearson, N.
    Factor, S. A.
    Juncos, J.
    Ramos, C. Serrano
    Brodsky, M.
    Manning, C.
    Marsh, L.
    Shulman, L.
    Fernandez, H. H.
    Black, K. J.
    Panisset, M.
    Christine, C. W.
    Jiang, W.
    Singer, C.
    Horn, S.
    Pfeiffer, R.
    Rottenberg, D.
    Slevin, J.
    Elmer, L.
    Press, D.
    Hyson, H. C.
    McDonald, W.
    NEUROLOGY, 2012, 78 (16) : 1229 - 1236
  • [39] ND0612 (levodopa/carbidopa for subcutaneous infusion) in patients with Parkinson's disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study
    Giladi, Nir
    Gurevich, Tanya
    Djaldetti, Ruth
    Adar, Liat
    Case, Ryan
    Leibman-Barak, Shelly
    Sasson, Nissim
    Caraco, Yoseph
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 139 - 145
  • [40] Amantadine infusion in treatment of motor fluctuations and dyskinesias in Parkinson's disease
    E. Růžička
    H. Streitová
    R. Jech
    P. Kaňovský
    J. Roth
    I. Rektorová
    P. Mečíř
    H. Hortová
    M. Bareš
    B. Hejduková
    I. Rektor
    Journal of Neural Transmission, 2000, 107 : 1297 - 1306
12345